ClinicalTrials.Veeva

Menu

Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

Pfizer logo

Pfizer

Status

Completed

Conditions

Plaque Psoriasis

Study type

Observational

Funder types

Industry

Identifiers

NCT00227240
0881A-101789

Details and patient eligibility

About

The purpose of this study is to investigate the incidences of adverse events for patients with plaque psoriasis treated with Enbrel under usual care settings.

Enrollment

753 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Proven diagnosis of Plaque Psoriasis

Exclusion criteria

  • Contraindications according to SmPC of Enbrel

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems